Profile for Canada Patent: 2780772
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Canada Patent: 2780772
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| ⤷ Start Trial | Nov 15, 2030 | Bristol | ZEPOSIA | ozanimod hydrochloride |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
